Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.

We describe folate receptor targeted thermosensitive magnetic liposomes, which are designed to combine features of biological and physical (magnetic) drug targeting for use in magnetic hyperthermia-triggered drug release. The optimized liposome formulation DPPC:cholesterol:DSPE-PEG(2000):DSPE-PEG(2000)-Folate at 80:20:4.5:0.5 molar ratio showed calcein release of about 70% both in PBS and in 50% FBS (fetal bovine serum) at 43 degrees C and less than 5% release at 37 degrees C following 1h incubation. Folate-targeted doxorubicin-containing magnetic liposomes of the above lipid composition (MagFolDox) showed encapsulation efficiencies of about 85% and 24% for doxorubicin and magnetic nanoparticles (mean crystallite size 10nm), respectively. This magnetic formulation displayed the desired temperature sensitivity with 52% doxorubicin release in 50% fetal bovine serum (FBS) following 1h incubation at 43 degrees C. MagFolDox, when physically targeted to tumor cells in culture by a permanent magnetic field yielded a substantial increase in cellular uptake of doxorubicin as compared to Caelyx (a commercially available liposomal doxorubicin preparation), non-magnetic folate-targeted liposomes (FolDox) and free doxorubicin in folate receptor expressing tumor cell lines (KB and HeLa cells). This resulted in a parallel increase in cytotoxicity over Caelyx and FolDox. Magnetic hyperthermia at 42.5 degrees C and 43.5 degrees C synergistically increased the cytotoxicity of MagFolDox. The results suggest that an integrated concept of biological and physical drug targeting, triggered drug release and hyperthermia based on magnetic field influence can be used advantageously for thermo-chemotherapy of cancers.

[1]  S. Loening,et al.  Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia , 2001 .

[2]  Y Rabin,et al.  Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[3]  H. Sakai,et al.  Effects of poly(ethylene glycol) (PEG) chain length of PEG-lipid on the permeability of liposomal bilayer membranes. , 2003, Chemical & pharmaceutical bulletin.

[4]  Samuel Zalipsky,et al.  Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. , 2004, Advanced drug delivery reviews.

[5]  W Andrä,et al.  Electromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice. , 2001, Radiology.

[6]  T. Brill,et al.  Advances in magnetofection—magnetically guided nucleic acid delivery , 2005 .

[7]  Jinming Gao,et al.  Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells , 2008 .

[8]  D. Tzemach,et al.  Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. , 1999, Bioconjugate chemistry.

[9]  Vladimir P Torchilin,et al.  Multifunctional nanocarriers. , 2006, Advanced drug delivery reviews.

[10]  Y. Negishi,et al.  Induction of cancer cell-specific apoptosis by folate-labeled cationic liposomes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[11]  M. Ranson,et al.  Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer. , 2001, Critical reviews in oncology/hematology.

[12]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .

[13]  Valérie Cabuil,et al.  Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. , 2005, Journal of the American Chemical Society.

[14]  S. Lesieur,et al.  Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution. , 2007, International journal of pharmaceutics.

[15]  D. Papahadjopoulos,et al.  Thermosensitive Sterically Stabilized Liposomes: Formulation and in Vitro Studies on Mechanism of Doxorubicin Release by Bovine Serum and Human Plasma , 1995, Pharmaceutical Research.

[16]  Jung Ho Yu,et al.  Designed Fabrication of a Multifunctional Polymer Nanomedical Platform for Simultaneous Cancer‐ Targeted Imaging and Magnetically Guided Drug Delivery , 2008 .

[17]  P. Low,et al.  Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. , 2005, Analytical biochemistry.

[18]  Hiroyuki Honda,et al.  Medical application of functionalized magnetic nanoparticles. , 2005, Journal of bioscience and bioengineering.

[19]  P. Low,et al.  Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. , 2004, Cancer letters.

[20]  Etienne Duguet,et al.  Magnetic nanoparticle design for medical applications , 2006 .

[21]  F. Zunino,et al.  DNA topoisomerase II as the primary target of anti-tumor anthracyclines. , 1990, Anti-cancer drug design.

[22]  Robert J. Lee,et al.  A folate receptor-targeted liposomal formulation for paclitaxel. , 2006, International journal of pharmaceutics.

[23]  Sanyog Jain,et al.  RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. , 2003, International journal of pharmaceutics.

[24]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[25]  H. Hofmann,et al.  Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system , 2005 .

[26]  Yu Zhang,et al.  Size dependence of specific power absorption of Fe3O4 particles in AC magnetic field , 2004 .

[27]  Christian Plank,et al.  Generation of magnetic nonviral gene transfer agents and magnetofection in vitro , 2007, Nature Protocols.

[28]  Pallab Pradhan,et al.  Preparation and characterization of manganese ferrite-based magnetic liposomes for hyperthermia treatment of cancer , 2007 .

[29]  T. Honda,et al.  Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice , 2008, Clinical Cancer Research.

[30]  Samuel Zalipsky,et al.  In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  P. Low,et al.  Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. , 1995, Biochimica et biophysica acta.

[32]  R. B. Campbell,et al.  The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. , 2007, Biomaterials.

[33]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[34]  Ho-Suk Choi,et al.  Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  Takashi Nakagawa,et al.  Suitability of commercial colloids for magnetic hyperthermia , 2009 .

[36]  Mark W Dewhirst,et al.  Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. , 2007, Journal of the National Cancer Institute.

[37]  M. Dewhirst,et al.  Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. , 1996, International journal of radiation oncology, biology, physics.

[38]  K. Krishnan,et al.  Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia , 2005 .

[39]  E. Ehlers,et al.  The effects of thermochemotherapy using cyclophosphamide plus hyperthermia on the malignant pleural mesothelioma in vivo. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[40]  F. Valeriote,et al.  Synergistic interaction of anticancer agents: a cellular perspective. , 1975, Cancer chemotherapy reports.

[41]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[42]  O. G. Mouritsen,et al.  The permeability and the effect of acyl-chain length for phospholipid bilayers containing cholesterol: theory and experiment. , 1992, Biochimica et biophysica acta.

[43]  C. Alexiou,et al.  Locoregional cancer treatment with magnetic drug targeting. , 2000, Cancer research.

[44]  U. Häfeli,et al.  Magnetically modulated therapeutic systems. , 2004, International journal of pharmaceutics.

[45]  A. Jordan,et al.  Clinical applications of magnetic nanoparticles for hyperthermia , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[46]  K. Kono,et al.  Thermosensitive polymer-modified liposomes. , 2001, Advanced drug delivery reviews.

[47]  T. Andresen,et al.  Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. , 2005, Progress in lipid research.

[48]  Hitoshi Sato,et al.  Preparation and Characterization of Dextran Magnetite-Incorporated Thermosensitive Liposomes: An on-line Flow System for Quantifying Magnetic Responsiveness , 1995, Pharmaceutical Research.

[49]  Takashi Sugita,et al.  Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet , 2004, International journal of cancer.

[50]  M. Dewhirst,et al.  The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. , 2001, Advanced drug delivery reviews.

[51]  Peter Wust,et al.  Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. , 2007, European urology.

[52]  J. Wijkander,et al.  Proton-induced membrane fusion. Role of phospholipid composition and protein-mediated intermembrane contact. , 1984, Biochimica et biophysica acta.

[53]  J. Stebbing,et al.  Pegylated liposomal doxorubicin (Caelyx) in recurrent ovarian cancer. , 2002, Cancer treatment reviews.

[54]  S. Libutti,et al.  Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect , 2007, Clinical Cancer Research.

[55]  Florence Gazeau,et al.  Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. , 2006, Radiology.

[56]  H. Grüll,et al.  A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery. , 2009, Journal of the American Chemical Society.